FDA decision: Ralinepag by United Therapeutics (on or before June 24, 2027)

FDA decision on Ralinepag on or before June 24, 2027 If the FDA's decision on Ralinepag by United Therapeutics on or before June 24, 2027 is a full approval or an accelerated approval, the market resolves to Yes. This market will resolve to No if the FDA's decision is a denial (CRL issued), a withdrawal by the sponsor, or a conditional approval — or if no decision is issued. This market will close early if the FDA issues a decision on Ralinepag before Jun 25, 2027